Viewing Study NCT06008106


Ignite Creation Date: 2025-12-26 @ 11:00 AM
Ignite Modification Date: 2026-01-01 @ 1:29 AM
Study NCT ID: NCT06008106
Status: RECRUITING
Last Update Posted: 2024-06-28
First Post: 2023-08-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma
Sponsor: Shanghai Kechow Pharma, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module